Why the study?
Cardiovascular disease and cancer share common risk factors, and complex interactions exist between hypertension and antineoplastic treatments.
Design
Review
Authors
Loading...
Supports integrated cardio-oncology care; leaves open causal effects of antihypertensives on cancer risk.
This review emphasizes the need for cardio-oncology strategies to manage the complex bidirectional interactions between hypertension and cancer therapies.
Sionakidis et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: